H.R. 1197

119 HR 1197 IH: PREEMIE Reauthorization Act of 2025
 U.S. House of Representatives
 2025-02-11
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 1197  IN THE HOUSE OF REPRESENTATIVES   February 11, 2025   Ms. Kelly of Illinois  (for herself,  Mrs. Miller-Meeks ,  Mrs. Fletcher ,  Mr. Carter of Georgia ,  Ms. Brown , and  Mrs. Kiggans of Virginia ) introduced the following bill; which was referred to the  Committee on Energy and Commerce    A BILL
To reauthorize the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act.
1.
Short title
This Act may be cited as the   PREEMIE Reauthorization Act of 2025  .
2.
PREEMIE
(a)
Research relating to preterm labor and delivery and the care, treatment, and outcomes of preterm and low birthweight infants
(1)
In general
Section 3(e) of the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act (42 U.S.C. 247b–4f(e)) is amended by striking  fiscal years 2019 through 2023  and inserting  fiscal years 2025 through 2029 .
(2)
Technical correction
Effective as if included in the enactment of the PREEMIE Reauthorization Act of 2018 ( Public Law 115–328 ), section 2 of such Act is amended, in the matter preceding paragraph (1), by striking  Section 2  and inserting  Section 3 .
(b)
Interagency working group
Section 5(a) of the PREEMIE Reauthorization Act of 2018 ( Public Law 115–328 ) is amended by striking  The Secretary of Health and Human Services, in collaboration with other departments, as appropriate, may establish  and inserting  Not later than 18 months after the date of the enactment of the  PREEMIE Reauthorization Act of 2025 , the Secretary of Health and Human Services, in collaboration with other departments, as appropriate, shall establish .
(c)
Study on preterm births
(1)
In general
The Secretary of Health and Human Services shall enter into appropriate arrangements with the National Academies of Sciences, Engineering, and Medicine under which the National Academies shall—
(A)
not later than 30 days after the date of enactment of this Act, convene a committee of experts in maternal health to study premature births in the United States; and
(B)
upon completion of the study under subparagraph (A)—
(i)
approve by consensus a report on the results of such study;
(ii)
include in such report—
(I)
an assessment of each of the topics listed in paragraph (2);
(II)
the analysis required by paragraph (3); and
(III)
the raw data used to develop such report; and
(iii)
not later than 24 months after the date of enactment of this Act, transmit such report to—
(I)
the Secretary of Health and Human Services;
(II)
the Committee on Energy and Commerce of the House of Representatives; and
(III)
the Committee on Finance and the Committee on Health, Education, Labor, and Pensions of the Senate.
(2)
Assessment topics
The topics listed in this subsection are each of the following:
(A)
The financial costs of premature birth to society, including—
(i)
an analysis of stays in neonatal intensive care units and the cost of such stays;
(ii)
long-term costs of stays in such units to society and the family involved post-discharge; and
(iii)
health care costs for families post-discharge from such units (such as medications, therapeutic services, co-payments for visits, and specialty equipment).
(B)
The factors that impact preterm birth rates.
(C)
Opportunities for earlier detection of premature birth risk factors, including—
(i)
opportunities to improve maternal and infant health; and
(ii)
opportunities for public health programs to provide support and resources for parents in-hospital, in non-hospital settings, and post-discharge.
(3)
Analysis
The analysis required by this subsection is an analysis of—
(A)
targeted research strategies to develop effective drugs, treatments, or interventions to bring at-risk pregnancies to term;
(B)
State and other programs’ best practices with respect to reducing premature birth rates; and
(C)
precision medicine and preventative care approaches starting early in the life course (including during pregnancy) with a focus on behavioral and biological influences on premature birth, child health, and the trajectory of such approaches into adulthood.